Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Basic) (2016 - 2026)

Organogenesis Holdings has reported EPS (Basic) over the past 10 years, most recently at $0.28 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 600.0% year-over-year to $0.28; the TTM value through Dec 2025 reached $0.12, up 700.0%, while the annual FY2025 figure was $0.16, 1700.0% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.28 at Organogenesis Holdings, up from $0.11 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.39 in Q4 2021 and troughed at -$0.17 in Q1 2025.
  • A 5-year average of $0.05 and a median of $0.04 in 2023 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): surged 1117.7% in 2023 and later plummeted 750.0% in 2025.
  • Year by year, EPS (Basic) stood at $0.39 in 2021, then plummeted by 84.62% to $0.06 in 2022, then crashed by 107.21% to -$0.0 in 2023, then surged by 1024.16% to $0.04 in 2024, then surged by 600.0% to $0.28 in 2025.
  • Business Quant data shows EPS (Basic) for ORGO at $0.28 in Q4 2025, $0.11 in Q3 2025, and -$0.1 in Q2 2025.